UTHR Financial Facts

Total operating expenses: 169.6M
Operating income: 238.6M
See Full Income Statement

Marketable investments: 79.6M
Inventories, net: 92.4M
See Full Balance Sheet

United Therapeutics Corp. (UTHR) Earnings

  |   Expand Research on UTHR
Next EPS Date 10/28/21 *Est. EPS Growth Rate +11.1% *Last Qtr.
Average EPS % Beat Rate +24.8% Revenue Growth Rate +23.3% *Last Qtr.
Average % Move 1-Wk after EPS +4.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/4/21 Q221 $4.09$3.02 +$1.07$446.5M$378.75M N/A Details
5/5/21 Q121 $3.49$2.94 +$0.55$379.1M$368.95M N/A Details
2/24/21 Q420 $3.31$3.14 +$0.17$384.9M$362.04M N/A Details
10/28/20 Q320 $3.88$2.78 +$1.10$380.1M$356.95M N/A Details
7/29/20 Q220 $3.68$2.86 +$0.82$362M$339.97M N/A Details
4/29/20 Q120 $3.61$2.72 +$0.89$356.3M$344.33M N/A Details
2/26/20 Q419 $1.96$2.65 -$0.69$311.1M$357.77M N/A Details
10/30/19 Q319 $3.83$2.47 +$1.36$401.5M$337.6M N/A Details